Severe Atrophic Gastritis with Extreme Hypergastrinemia and Gene Expression of Ornithine Decarboxylase (Odc) and Cyclo-Oxygenase-2 (Cox-2) Expression: Comparison with Gastric Cancer [5]

Journal of Clinical Gastroenterology

Volumn 38, Issue 1, 2004, Pages 87-89

  Konturek, Stanislaw J ^a   Bielanski, W ^a   Gruchala, A ^a   Stachura, J ^a   Czesnikiewicz, M ^a   Bobrzyński, Andrzej ^a   Konturek, Peter C ^b   Hahn, Eckhard G ^b  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; BIOCHEMICAL MARKER; CLARITHROMYCIN; CYCLOOXYGENASE 2; OMEPRAZOLE; ORNITHINE DECARBOXYLASE; PROGASTRIN; PROTON PUMP INHIBITOR;

ADULT; AGED; ATROPHIC GASTRITIS; CLINICAL ARTICLE; DYSPEPSIA; GASTRITIS; GASTROINTESTINAL ENDOSCOPY; GENE EXPRESSION; HELICOBACTER PYLORI; HUMAN; HYPERGASTRINEMIA; LETTER; NONHUMAN; PRIORITY JOURNAL; STOMACH CANCER; STOMACH CARCINOGENESIS; STOMACH MUCOSA; UREA BREATH TEST;

AGED; DIAGNOSIS, DIFFERENTIAL; FEMALE; GASTRINS; GASTRITIS, ATROPHIC; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MIDDLE AGED; ORNITHINE DECARBOXYLASE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; STOMACH NEOPLASMS;

EID: 0348010267     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-200401000-00022     Document Type: Letter

References (10)

1. Wolfe MM, Jensen RT. Zollinger-Ellison syndrome: current concepts in diagnosis and management. N Engl J Med. 1987;317:1200-1209.
2. Hori, K, Fukui H, Imura J et al. Benign gastric carcinoid tumor with hypergastrinemia followed up for 12 years. Gastric Cancer. 2000;27;3(3):161-164.
3. Konturek S, Konturek P, Bielanski W, et al. Case presentation of astrinoma combined with gastric carcinoid with the longest survival record - Zollinger-Ellison syndrome: pathophysiology, diagnosis and therapy. Med. Sci Monit. 2002;8:CS43-CS59.
4. Dockray GJ, Varro A, Dimaline R, et al. The gastrins: their production and biological activities. Annu Rev Physiol. 2001;63:119-139.
5. Bielanski W, Konturek SJ. New approach to 13-urea urea breath test: capsule-based modification of 13C-urea breath test in diagnosis of Helicobacter pylori infection. J Physiol Pharmacol. 1996;47:545-553.
6. Van Rees BP, Ristimäki BP: Cyclooxygenase-2 in carcinogenesis of the gastrointestinal tract. Scand J Gastroenterol. 9:897-901,200.
7. Konturek PC, Kania J, Kuharsky V, et al. Influence of gastrin on the expression of cyclooxygenase-2, hepatocyte growth factor and apoptosis related proteins in gastric cancer cells. J Physiol Pharmacol. 2003;55:17-32.
8. Konturek PC, Rembiasz K, Konturek SJ, et al. Gene expression of omithine decarboxylase, cyclooxygenase-2 and gastrin in atrophic gastric mucosal infected with Helicobacter pylori and after eradication therapy. Dig Dis Sci. 2003;48:36-46.
9. Konturek PC, Konturek SJ, Bielanski W, et al. The influence of COX-2 inhibition by rofexicoxib on serum and tumor progastrin and gastrin levels and expression of PPARγ and apoptosis-related proteins in gastric cancer patients. Dig Dis Sci. 2003;(in press)
10. Konturek PC, Konturek SJ, Sulekova Z, et al. Expression of growth factor, transforming growth factor alpha, apoptosis related proteins Bax and BCI-2 gastrin in human gastric cancer. Aliment Pharmacol Ther. 2001;15:989-999.